News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
416,287 Results
Type
Article (29016)
Company Profile (131)
Press Release (387140)
Section
Business (110682)
Career Advice (604)
Deals (19018)
Drug Delivery (73)
Drug Development (42422)
Employer Resources (80)
FDA (10987)
Job Trends (10362)
News (188836)
Policy (21252)
Tag
Academia (2263)
Alliances (31202)
Alzheimer's disease (846)
Approvals (10957)
Artificial intelligence (102)
Bankruptcy (151)
Best Places to Work (9171)
Biosimilars (54)
Biotechnology (75)
Breast cancer (71)
Cancer (569)
Cardiovascular disease (58)
Career advice (550)
Cell therapy (103)
Clinical research (33343)
Collaboration (241)
COVID-19 (2188)
Data (617)
Diabetes (95)
Diagnostics (5420)
Drug pricing (78)
Earnings (35295)
Employer resources (70)
Events (74411)
Executive appointments (173)
FDA (11331)
Funding (219)
Gene therapy (79)
GLP-1 (332)
Government (4105)
Healthcare (15391)
Infectious disease (2261)
Inflammatory bowel disease (72)
Interviews (68)
IPO (8049)
Job creations (1501)
Job search strategy (501)
Layoffs (162)
Legal (3997)
Lung cancer (92)
Manufacturing (100)
Medical device (9319)
Medtech (9322)
Mergers & acquisitions (11037)
Metabolic disorders (265)
Neuroscience (994)
NextGen Class of 2024 (5129)
Non-profit (3985)
Northern California (806)
Obesity (169)
Opinion (109)
People (34967)
Phase I (10888)
Phase II (13250)
Phase III (11567)
Pipeline (202)
Postmarket research (1616)
Preclinical (4099)
Press Release (55)
Radiopharmaceuticals (161)
Rare diseases (131)
Real estate (3063)
Regulatory (14021)
Research institute (2022)
Southern California (648)
Startups (2271)
United States (7883)
Vaccines (443)
Weight loss (111)
Date
Today (154)
Last 7 days (698)
Last 30 days (2129)
Last 365 days (23274)
2024 (20290)
2023 (25967)
2022 (35527)
2021 (39106)
2020 (39345)
2019 (34650)
2018 (25962)
2017 (19258)
2016 (20284)
2015 (23251)
2014 (17288)
2013 (13957)
2012 (14663)
2011 (15195)
2010 (13131)
Location
Africa (532)
Arizona (98)
Asia (22474)
Australia (4017)
California (1704)
Canada (820)
China (141)
Colorado (86)
Connecticut (104)
Europe (51416)
Florida (266)
Georgia (85)
Illinois (223)
Indiana (168)
Kansas (73)
Maine (57)
Maryland (374)
Massachusetts (1389)
Michigan (96)
Minnesota (145)
New Jersey (643)
New York (559)
North Carolina (475)
Northern California (806)
Ohio (93)
Pennsylvania (521)
South America (705)
Southern California (648)
Texas (221)
Utah (76)
Washington State (245)
416,287 Results for "molecular health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Integrated DNA Technologies and Molecular Health Ink Commercial Partnership
Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities.
May 15, 2024
·
6 min read
Collaboration
Novartis Inks Potential $2.2B Molecular Glue Deal With Monte Rosa
The Swiss pharma is paying $150 million upfront to gain rights to Monte Rosa’s VAV1-targeting molecular glue degraders, led by a Phase I candidate which holds therapeutic promise for immune-mediated diseases.
October 28, 2024
·
2 min read
·
Tristan Manalac
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
Biogen touted strong Q3 sales of its Alzheimer’s drug Leqembi a day after announcing a deal worth up to $1.45 billion with Neomorph to discover and develop molecular glue degraders.
October 30, 2024
·
2 min read
·
Heather McKenzie
Business
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
Specialty cancer diagnostics company Precipio, Inc. announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products.
February 6, 2024
·
3 min read
Business
Degron Therapeutics Announces Multi-Target Collaboration and Exclusive License Agreement with Takeda to Discover Molecular Glue Degraders
Degron Therapeutics, the company using its molecular glue-based targeted protein degradation drug-discovery platform to advance human health, announced it has entered into a collaboration and exclusive license agreement with Takeda to discover and develop novel molecular glue degraders for multiple targets in oncology, neuroscience, and inflammation.
May 23, 2024
·
3 min read
Biotech Bay
Alveo’s Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests
Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced the results of rigorous testing that demonstrate the ruggedness of its portable molecular testing platform.
June 18, 2024
·
3 min read
Pharm Country
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA Sciences, Inc. announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC, will utilize the GenXys Health Care Systems suite of clinical decision support software for interpretation and reporting of ADCL’s New York State Department of Health-approved TR8™ pharmacogenomic test.
June 18, 2024
·
5 min read
Business
DiaCarta and Capstone Health Alliance Collaborate to Bring Revolutionary Diagnostic Tests to Enhance Patient Care
DiaCarta, Inc. (“DiaCarta”), a pioneer in developing innovative molecular technologies to transform patient care by providing effective precision diagnostics using liquid biopsy in cancer and infectious diseases has established a strategic collaboration with Capstone Health Alliance, one of the largest regional group purchasing organizations (GPO) in the US healthcare sector.
June 26, 2024
·
3 min read
Business
Calyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents
Calyx / Invicro, a global leader in providing medical imaging solutions and development services to the clinical research community, announces a strategic partnership with BAMF Health, a world leader in molecular imaging and theranostics.
June 7, 2024
·
3 min read
Lone Star Bio
Molecular Templates, Inc. Provides Interim Update
Molecular Templates, Inc. today provided an update on its clinical-stage programs.
June 3, 2024
·
7 min read
1 of 41,629
Next